| 17beta-estradiol | affects expression | ISO | RGD:1317506 | 6480464 | Estradiol affects the expression of BCR mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | increases expression | ISO | RGD:1317506 | 6480464 | Estradiol results in increased expression of BCR mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317506 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BCR mRNA | CTD | PMID:11007951 |
| 2-butoxyethanol | decreases expression | ISO | RGD:1615754 | 6480464 | n-butoxyethanol results in decreased expression of BCR mRNA | CTD | PMID:19812364 |
| ATP | multiple interactions | ISO | RGD:1317506 | 6480464 | [BCR protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein; more ... | CTD | PMID:19366808 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1615754 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of BCR mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1615754 | 6480464 | Benzo(a)pyrene results in decreased expression of BCR mRNA | CTD | PMID:19770486 |
| chlorpyrifos | increases expression | ISO | RGD:1317506 | 6480464 | Chlorpyrifos results in increased expression of BCR protein | CTD | PMID:16790487 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of BCR mRNA | CTD | PMID:18668222 |
| cobalt dichloride | decreases expression | ISO | RGD:1317506 | 6480464 | cobaltous chloride results in decreased expression of BCR mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1317506 | 6480464 | Copper Sulfate results in decreased expression of BCR mRNA | CTD | PMID:19549813 |
| cyfluthrin | increases expression | ISO | RGD:1317506 | 6480464 | cyfluthrin results in increased expression of BCR protein | CTD | PMID:16790487 |
| dasatinib (anhydrous) | affects binding | ISO | RGD:1317506 | 6480464 | dasatinib binds to BCR protein mutant form | CTD | PMID:17684099 PMID:18180381 |
| dasatinib (anhydrous) | decreases phosphorylation | ISO | RGD:1317506 | 6480464 | dasatinib results in decreased phosphorylation of BCR protein mutant form | CTD | PMID:17020995 PMID:19878872 |
| dasatinib (anhydrous) | affects binding | ISO | RGD:1317506 | 6480464 | dasatinib binds to BCR protein mutant form | CTD | PMID:18180381 PMID:17684099 |
| dasatinib (anhydrous) | decreases phosphorylation | ISO | RGD:1317506 | 6480464 | dasatinib results in decreased phosphorylation of BCR protein mutant form | CTD | PMID:17020995 |
| dasatinib (anhydrous) | decreases activity | ISO | RGD:1317506 | 6480464 | dasatinib results in decreased activity of BCR protein mutant form | CTD | PMID:19100678 |
| dasatinib (anhydrous) | multiple interactions | ISO | RGD:1317506 | 6480464 | dasatinib inhibits the reaction [BCR protein mutant form results in increased phosphorylation of CRKL protein] | CTD | PMID:19100678 |
| dasatinib (anhydrous) | multiple interactions | ISO | RGD:1317506 | 6480464 | [dasatinib co-treated with vorinostat] results in decreased expression of BCR protein mutant form; more ... | CTD | PMID:17020995 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of BCR mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCR mRNA] | CTD | PMID:20032058 |
| diarsenic trioxide | decreases expression | ISO | RGD:1317506 | 6480464 | arsenic trioxide results in decreased expression of BCR mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | increases expression | ISO | RGD:1317506 | 6480464 | arsenic trioxide results in increased expression of BCR mRNA | CTD | PMID:22521957 |
| diarsenic trioxide | decreases expression | ISO | RGD:1317506 | 6480464 | arsenic trioxide results in decreased expression of BCR protein mutant form | CTD | PMID:14633726 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of BCR mRNA | CTD | PMID:21266533 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of BCR mRNA | CTD | PMID:18253720 |
| gallic acid | multiple interactions | ISO | RGD:1317506 | 6480464 | Gallic Acid promotes the reaction [imatinib results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]; more ... | CTD | PMID:22245431 |
| histamine | multiple interactions | ISO | RGD:1317506 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; more ... | CTD | PMID:16849647 |
| imatinib | multiple interactions | ISO | RGD:1317506 | 6480464 | imatinib results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] | CTD | PMID:22397755 |
| imatinib | decreases phosphorylation | ISO | RGD:1317506 | 6480464 | imatinib results in decreased phosphorylation of BCR protein mutant form | CTD | PMID:19366808 PMID:19878872 |
| imatinib | multiple interactions | ISO | RGD:1317506 | 6480464 | imatinib promotes the reaction [Gallic Acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]; more ... | CTD | PMID:22245431 |
| imatinib | decreases activity | ISO | RGD:1317506 | 6480464 | imatinib results in decreased activity of BCR protein mutant form | CTD | PMID:15604220 PMID:15329907 |
| imatinib | multiple interactions | ISO | RGD:1317506 | 6480464 | [vorinostat co-treated with imatinib] results in decreased expression of BCR protein mutant form; more ... | CTD | PMID:12446442 |
| imatinib | decreases phosphorylation | ISO | RGD:1317506 | 6480464 | imatinib results in decreased phosphorylation of BCR protein mutant form | CTD | PMID:19366808 |
| imatinib | decreases activity | ISO | RGD:1317506 | 6480464 | imatinib results in decreased activity of BCR protein mutant form | CTD | PMID:15329907 PMID:15604220 |
| imatinib | multiple interactions | ISO | RGD:1317506 | 6480464 | imatinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; more ... | CTD | PMID:16849647 |
| LY294002 | multiple interactions | ISO | RGD:1317506 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; more ... | CTD | PMID:16849647 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of BCR mRNA | CTD | PMID:18253720 |
| quercetin | decreases expression | ISO | RGD:1317506 | 6480464 | Quercetin results in decreased expression of BCR mRNA | CTD | PMID:14715546 |
| resveratrol | multiple interactions | ISO | RGD:1317506 | 6480464 | purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] | CTD | PMID:22397755 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCR mRNA] | CTD | PMID:20032058 |
| theophylline | increases expression | ISO | RGD:1317506 | 6480464 | Theophylline results in increased expression of BCR mRNA | CTD | PMID:16083514 |
| trans-resveratrol | multiple interactions | ISO | RGD:1317506 | 6480464 | purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] | CTD | PMID:22397755 |
| zinc atom | multiple interactions | ISO | RGD:1317506 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of BCR mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1317506 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of BCR mRNA | CTD | PMID:18593933 |